1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
Global Mammography Systems Market Size, Share & Industry Trends Analysis Report By Product Type, By Modality, By End User, By Regional Outlook and Forecast, 2022 – 2028

Global Mammography Systems Market Size, Share & Industry Trends Analysis Report By Product Type, By Modality, By End User, By Regional Outlook and Forecast, 2022 – 2028

  • April 2022
  • 196 pages
  • ID: 6283446
  • Format: PDF
  • KBV Research


Table of Contents

The Global Mammography Systems Market size is expected to reach $3.6 billion by 2028, rising at a market growth of 7.2% CAGR during the forecast period.

Mammography is a type of medical imaging approach that involves using a low-dose x-ray device to observe and identify malfunctions in the breasts. Breast cancer as well as other breast-related disorders can be detected more easily with mammography. Females can use these tests to detect and diagnose breast cancer.

Breast cancer is one of the most serious health problems that women face around the world. In the United States, for example, a significant number of new instances of invasive breast cancer would be identified in women in 2022, compared to fewer new cases of non-invasive breast cancer. Throughout their life, few of American women will get invasive breast cancer. The need for mammography systems is expected to rise as a result of this. Because of an increase in the prevalence of breast cancer, the increase in the geriatric population, and proactive measures by healthcare institutions to spread awareness about early diagnosis of breast cancer, this market is likely to develop significantly over the forecast period.

Breast cancer was the most common type of cancer in 2020, according to a Globocan analysis, with a prevalence incidence of 11.7 percent. As per the same research, Asia had the highest prevalence rate for both sexes, followed by Europe, and North America. The increasing frequency of breast cancer is one of the key reasons for the predicted rise in demand for mammography systems, which can be utilized for diagnostic purposes.

As per data from the Centers for Disease Control and Prevention (CDC), breast cancer is amongst the most common cancers among women, irrespective of race or ethnicity. In women all over the world, it’s also the third-leading cause of cancer death. Mammography makes it easier to diagnose breast cancer and other breast-related illnesses. Patients are only exposed to a little quantity of ionizing radiation because mammography uses x-rays to take images of the breast, as per the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Patients are only exposed to a little quantity of ionizing radiation because mammography uses rays to take images of the breast, as per the National Institute of Biomedical Imaging and Bioengineering (NBIB).

COVID-19 Impact

Because of social distancing measures imposed by governments around the world, the COVID-19 pandemic had a tremendous impact on Mammography Companies. Hospital and healthcare services were radically reduced. Moreover, the COVID-19 pandemic had a substantial impact not only on the global economy but also on the operation of general hospital treatment for non-COVID-19 patients in hospitals all over the world. Because many hospitals & screening institutions were closed owing to lockdowns, it reduced the delivery of the mammography procedures. Cancer screening, cancer management visits, and cancer operations have all decreased significantly as a result of the COVID-19 pandemic.

Market Growth Factors

Increasing Breast Cancer Incidence

The developments in female healthcare have contributed to the growth of the mammography systems market. Women are predisposed to several diseases that are unique to the female gender. This has increased the medical industry’s concerns about delivering high-quality care & analysis of diseases that affect women. For more than a decade, mammography systems are being used in the healthcare industry. Their technology and systems, on the other hand, have advanced dramatically in recent years. These evident developments in the construction, operation, and configuration of mammography systems are the result of evolving demands for diagnosing disorders of the breast. As a result, the mammography systems market is expected to grow rapidly in the coming years.

Increasing demand for digital mammography

They also have the benefit of soft-copy visual displays & soft-copy reading, both of which are easily transferable. Digital mammography screening is now available in many nations, including the United Kingdom, and provides greater accuracy, improved quality, and efficiency. As a result, even though digital mammography is six times more expensive than traditional methods, it is becoming the primarily preferred method of screening. When compared to analog systems, radiation exposure is drastically reduced. The most prevalent type of digital mammography is full-field digital mammography. It has the potential to lead to major improvements in breast cancer diagnostics, such as lower radiation doses, lowered breast compression pressure, and improved detection.

Market Restraining Factors

Risks from Radiation and Other Hazards

A modest amount of radiation is used in mammography. Based on the scale & compression of the breasts, the individual dose may vary. However, due to contemporary mammography techniques, particularly full-field digital mammography, the glandular dose has reduced dramatically over the last few decades and continues to do so. The risk of radiation can also be seen in people with aging 40 or above. In nowadays, a 50-year-old woman’s natural lifetime risk of developing breast cancer is approximately 8.8%. A certain percentage of this risk may increase to 8.9% if a woman has biennial screening mammography between the ages of 50 and 69.

Product Type Outlook

Based on Product Type, the market is segmented into Analog and Digital. The Analog Mammography segment acquired highest revenue share in the mammography systems market in 2021. Analog Mammography Devices are classic mammography systems that use film to capture x-ray pictures. Before viewing these films/detectors for a precise diagnosis of breast cancer, they must first be developed. An X-ray unit’s analogue image detector is made up of three parts: an intensifying screen, X-ray film, and a light-proof container (cassette). This imaging system includes the developing apparatus, as well as reagents for photochemical processing of X-ray films (fixing agent, developer, water) and the dryer. X-ray film is made consisting of a thin, translucent, flexible polyester film (the X-ray film’s base material) and a thin coating of photographic emulsion. The emulsion is coated with protective polymer layers & a dulling agent. Photosensitive elements are silver halide microcrystals. Quanta of X-ray or visible light radiation energy emitted by intensifying screens immediately transfer their energy to silver halide crystals.

Modality Outlook

Based on Modality, the market is segmented into Portable and Non-Portable. The Non-Portable Mammography system segment procured significant revenue share in the mammography systems in 2021. If the practice is being performed in-house and there is a lack of space, a fixed unit may be more cost-effective because they include extra features like larger detectors & better compression mechanisms.

End User Outlook

Based on End User, the market is segmented into In-patient Settings and Ambulatory Surgical Centers. The Inpatient settings segment acquired highest revenue share in the mammography systems market in 2021. Inpatient care is used to address conditions that necessitate the patient staying in a care facility for at least one night. Rehabilitation centres, acute care facilities, addiction treatment facilities, mental hospitals, and long-term care facilities are all included in this category. Additional facility-based fees apply to inpatient care. According to the most recent cost statistics from the Agency for Healthcare Research and Quality’s Cost and Utilization Project, median national inpatient fees vary substantially depending on the length of stay & the therapy offered.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America procured the largest revenue share of the mammography system market. Because of its well-established healthcare facilities, presence of top market players, rising focus on developed healthcare infrastructure, preventive care, aging population, and an increasing number of product launches, the mammography systems market in the United States is predicted to develop. In addition, advancements in imaging technology, rising breast cancer prevalence, and rising need for enhanced patient diagnostics in the United States & Canada are increasing the usage of mammography systems, resulting in increased demand for these goods. Hence, the regional market is flourishing.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; General Electric (GE) Co. and Siemens AG are the forerunners in the Mammography Systems Market. Companies such as Fujifilm Holdings Corporation, Canon, Inc., Hologic, Inc. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens AG, Fujifilm Holdings Corporation, Canon, Inc., General Electric (GE) Co., Hologic, Inc., Koninklijke Philips N.V., Metaltronica S.p.A., Allengers Medical Systems Ltd., Planmed Oy, and Konica Minolta, Inc.

Recent strategies deployed in Mammography Systems Market

Partnerships, Collaborations and Agreements:

Jun-2021: Royal Philips teamed up with Akumin, a top provider of outpatient diagnostic imaging services in the U.S. The collaboration aimed to incorporate Philips’ NEW Radiology Operations Command Center all over Akumin’s outpatient imaging centers & co-create clinical standards for MR and CT imaging modalities of Akumin.

Oct-2020: The Fujifilm Medical Systems extended its partnership with Volpara Solutions. This partnership aimed to deliver facilities of mammography & clinicians with solutions for breast imaging created to enhance the quality of image, precise assessment of a patient’s breast density, and streamline workflow.

Sep-2020: Candelis teamed up with General Electric Healthcare to improve the image management, mammography workflow, and storage capabilities for Senographe Pristina Mammography Systems. This collaboration aimed to improve the mammography workflow, image management, and storage capabilities for the Senographe Pristina Mammography System.

Aug-2020: Hologic joined hands with RadNet, a provider of fixed-site outpatient diagnostics imaging services. This collaboration aimed to advance the use of artificial intelligence (A.I) in breast health.

Aug-2020: Canon Medical Systems USA formed a partnership with Zebra Medical Vision, a computer vision startup focused on health care. This partnership aimed to deliver its AI1 automated imaging analysis solutions to assist clinicians in the U.S to deliver quicker, precise diagnoses for optimized patient care.

Product Launches and Product Expansions:

Apr-2021: The Fujifilm Holding Corporation unveiled the new "Harmony" version of its existing Amulet Innovality mammography system. This version makes the combination of bettered diagnostic performance and innovative design themes light up the mammography system, which makes the patient feel at home and comfortable.

Mar-2021: Siemens Healthineers expanded its product line with the introduction of Mammovista B.smart, a new software solution. This solution would fasten up the whole reading workflow for breast imaging and another new tool named Teamplay Mammo Dashboard for dashboard-based visualization of key performance indicators process of breast imaging that serves to a better workflow. These new solutions would expand its digital offerings for breast care.

Oct-2020: The Hologics introduced the new product 3DQuorum Imaging Technology for commercial use. The purpose behind the introduction of this product is to assist in improving mammography efficiency & workflow. In addition, this product is as critical as clinics seek to manage the backlog of women whose regular breast screening was delayed because of the COVID-19 lockdown.

Acquisitions and Mergers:

Jul-2021: Siemens Healthineers took over Varian Medical Systems, an American radiation oncology treatments & software maker located in Palo Alto, California. This acquisition aimed to incorporate a robust & trusted partner capable of supporting patients & customers with the whole cancer care continuum and also all major clinical pathways.

May-2021: General Electric Healthcare signed an agreement to acquire ZIONEXA, a top innovator of neurology biomarkers and in-vivo oncology, that assists in more customized healthcare. This acquisition aimed to create and bring ZIONEXA’s pipeline biomarkers, and even Cerianna which is FDA approved PET imaging agent to the market. This product is utilized as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to assist in informing the treatment selection for patients with metastatic breast cancer or recurrent breast cancer.

Jan-2021: Hologic completed the acquisition of Somatex Medical Technologies, a biopsy site markers & localization technologies provider. This acquisition aimed to support the medical technology company’s strategy to offer innovative solutions all over the continuum of breast health care. This acquisition deal would assist the company to expand its growing biopsy portfolio.

Approvals and Trials:

Nov-2021: Siemens Healthineers received approval from U.S Food & Drug Administration (FDA) for two new mammography reading and workflow optimization solutions. This approval would widen the company’s offering for breast health.

Aug-2021: The Fujifilm Holding Corporation received FDA approval for ScreenPoint Medical’s new, Transpara powered by Fusion AI 2D & 3D mammography in the United States. This approval shows breast screening results at the reading workstation of a doctor or PACS system.

Dec-2020: Hologics’s Genius AI software received approval from the U.S Food & Drug Administration. This Genius AI is software for early breast detection with tomosynthesis, and it is the sole CAD product that assists its Clarity HD & 3DQuorum imaging technology, which are its most developed packages for breast tomosynthesis.

Scope of the Study

Market Segments covered in the Report:

By Product Type

• Analog

• Digital

By Modality

• Portable

• Non-Portable

By End User

• In-patient Settings

• Ambulatory Surgical Centers

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Siemens AG

• Fujifilm Holdings Corporation

• Canon, Inc.

• General Electric (GE) Co.

• Hologic, Inc.

• Koninklijke Philips N.V.

• Metaltronica S.p.A.

• Allengers Medical Systems Ltd.

• Planmed Oy

• Konica Minolta, Inc.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Mammography Market Size, Share & Trends Analysis Report By Product, By Technology, By Region And Segment Forecasts, 2022 - 2030

  • $ 5950
  • June 2022
  • 90 pages

Mammography Market Size, Share & Trends Analysis Report By Product (Film Screen, Digital, Analog, Biopsy Systems, 3D Systems), By Technology (Breast Tomosynthesis, CAD, Digital), By Region, And Segment ...

  • World
  • Australia
  • Mammography Equipment
  • Industry analysis
  • Drug Approval
  • Breast Screening Coverage


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on